PER 2.70% 7.6¢ percheron therapeutics limited

Wow!..92 % reduction.. Who said Antisense Gen2 was useless......

  1. 13,150 Posts.
    lightbulb Created with Sketch. 1382
    Wow!..92 % reduction..
    Who said Antisense Gen2 was useless...

    ISIS-TTRRx is a gen 2.0+ antisense drug Isis is developing with GSK for the treatment of TTR amyloidosis.  ISIS-TTRRx is administered as a once weekly subcutaneous injection and is designed to inhibit the production of all forms of TTR protein, including both mutant and wild type, offering a unique approach to treat all types of TTR amyloidosis.

    Read more: http://www.nasdaq.com/press-release...-ttr-amyloidosis-20150422-01191#ixzz3Y7xnLI2R
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.6¢
Change
0.002(2.70%)
Mkt cap ! $67.61M
Open High Low Value Volume
7.5¢ 7.6¢ 7.5¢ $29.46K 393.5K

Buyers (Bids)

No. Vol. Price($)
1 7453 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
7.7¢ 15846 3
View Market Depth
Last trade - 11.48am 07/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.